NGFI-A, and Zif268, is a zinc finger transcription factor that was identified as an immediate-early serum response gene expressed in various physiological conditions (Milbrandt, 1987; Topilko et al., 1998) . Egr1 belongs to Egr family of transcription factors encoding closely related transcription factors (Patwardhan et al., 1991) . It is rapidly induced by various stimuli such as growth factors and cytokines. It can be expressed through activation of the protein kinase C and mitogen-activated protein kinase pathways (Gashler and Sukhatme, 1995) . These pathways are activated by gonadotropin releasing hormone (GnRH) in gonadotropes (Sundaresan et al., 1996; Reiss et al., 1997; Saunders et al., 1998) .
Two independent Egr1 knock-out mice with overlapped and distinct phenotypes have been produced (Lee et al., 1996; Topilko et al., 1998) . Two different cell lineages expressing Egr1 in the pituitary are differentially affected by the mutation. Somatotropes present abnormal cytological features and are reduced in number, consistent with the decreased level of growth hormone observed in these animals. In contrast, gonadotropes are normal in number, but fail to synthesize the β-subunit of luteinizing hormone (LHβ). In the ovary, expression of LH receptor is downregulated, indicating that Egr1 could act at two different levels of the pituitary-gonadal axis (Duan et al., 2002; Yoshino et al., 2002) . While it is now clear that Egr1 is a critical transcription factor to regulate LHβ transcription in the pituitary, its function and target genes in other reproductive organs such as uterus have not been thoroughly investigated.
Egr1 acts as tumor suppressor by trans-activating major tumor suppressors, including transforming growth factor-β1, p53, and PTEN, indicating that Egr1 is a major tumor suppressor in numerous human cancers (Baron et al., 2006) . For example, Egr1 expression is suppressed in nonsmall cell lung cancers and glioblastomas. Over-expression of Egr1 by recombinant adenovirus infection almost completely prevents the growth of tumor cells in vitro, regardless of the mutation of the p53 gene in breast cancer and small cell lung carcinoma (Calogero et al., 2004) . Egr1 regulates transcription of heparanase in tumor cells by either repressing or activating transcription depending on types of cancers (de Mestre et al., 2005) . Furthermore, Egr1 is induced by estrogen via ERK1/2-dependent activation of ELK-1 in MCF-7 breast cancer cells (Chen et al., 2004) .
However, the function and expression profiles of Egr1 have not been investigated in the uterus, a major target tissue of estrogen. Thus, it is critical to identify target genes whose transcription is directly regulated by Egr1 in the uterus for understanding function and estrogen-dependent regulation of Egr1 in the uterus. Here we suggest that multi-step in silico analyses with mRNA microarray data could be a useful tool to provide a list of genes with higher probability to be direct target genes of a transcription factor for further functional studies. (Lee et al., 1996) . Six to seven week-old Egr1(+/+) and Egr1 (-/-) female mice were ovariectomized (OVX), rested for 2 weeks, and then treated with 200 ng estrogen (17-estrodiol, E 2 ). Mice were sacrificed 3 h after E 2 treatment and uterine tissues were collected for RNA preparation.
Total RNA from each mouse was individually prepared and two RNA samples were pooled for each microarray.
mRNA microarrays were performed with Illumina Mouse WG-6 V2 (48K) array (Illumina; San Diego, CA, USA).
Microarrays were performed as triplicates for each genotype (n=6 mice per genotype). Significant Analyses of Microarray (SAM) was applied to select DEGs between Egr1(+/+) and Egr1(-/-) uteri after E 2 treatment.
In silico promoter analyses of DEGs
The promoter sequences of DEGs from -2000 to +200
[a reference point (zero) was transcription start site] were obtained from UCSC gene sorter (http://www.genome. ucsc.edu). MatInspector (http://www.genomatix.de) was applied to mouse promoter sequences to identify putative EBSs in the promoter regions of DEGs (Cartharius et al., 2005) . Three most representative EBSs provided by MatBase in genomatix were utilized to identify putative EBS in promoter regions. All the promoter sequences from seven species, including mouse, rat, human, rhesus monkey, orangutan, horse and dog, were applied to Promo (http:// alggen.lsi.upc.es) for analyzing sequence conservation of EBS among different species (Messeguer et al., 2002) . gene-specific primers were used as described in Table 1 .
The PCR conditions for all primers were as follows: hold for 10 min at 95℃, followed by each cycles which were determined by primer test consisting of denaturation at 95℃ (30 sec), annealing at 60℃ (30 sec), elongation at 72℃ (1 min). The amplified products were subjected to electrophoresis on a 2% agarose gel. Real-time RT-PCR was performed using Real-time PCR detection system and then used to calculate the relative abundance of each gene as previously described (Svaren et al., 2000) . Values were then normalized to the relative amounts of rPL7
cDNA. All PCR reactions were performed in duplicate.
Statistical analyses
All values represent the mean±standard error (SE is significantly higher than that of non-DEG (p<0.01),
suggesting that -500 bp promoter is the critical region for EGR1 to regulate transcription of its direct target genes.
Correlation of expression values of DEGs with the frequency of EBSs in their promoters
As shown in Fig. 2C , the promoter of each DEG has a wide spectrum with respect to the number of EBS. To examine whether the number of putative EBS in the promoters of DEGs is associated with expression levels of DEGs, fold changes of 60 down-regulated DEGs and the frequencies of EBSs on their promoters (~-2kb) were analyzed. Fig. 3 clearly showed that the frequency of putative EBSs on the promoter is not correlated with expression levels of DEGs. For example, Frmd6 with more than 10 EBSs on its promoter had 1.5 fold changes and Ddit4l with only one EBS was the most down-regulated gene among DEGs.
Promoter analyses to examine sequence conservation of EBSs in the promoter region of DEGs
To efficiently identify biologically active EBS on the promoter of DEGs with bioinformatic tools, it has been examined whether the promoter sequences of DEGs were conserved between species. Promoter sequences of DEGs were collected from seven different species as much as their promoter sequences are available and analyzed by using Promo. In silico analyses with Promo provided that 11 EBS in 9 DEGs were highly conserved between species, among 276 EBS in the promoters of 102 DEGs (Fig. 4) .
Interestingly, 10 out of 11 highly conserved EBS were located within -0.5 kb of DEGs' promoters.
Validation of expression levels of DEGs with highly conserved EBS in their promoters

RT-PCR was performed to validate expression levels of
DEGs with highly conserved EBS in their promoters.
Among 9 genes whose promoters have been extensively investigated in this study, 7 genes were differentially expressed between uteri of OVX Egr1(+/+) and Egr1(-/-) mice (Fig. 5A ). Real-time RT-PCR results showed that all 7 DEGs including Lbh, Egr2, Kit and Adamts-1 were significantly down-regulated in Egr1(-/-) uteri 3 h after estrogen treatment (Fig. 5B) . A time-course expression profile of Gadd45g seems to be a replica of Egr1, suggesting that Gadd45g could be one of the target genes regulated by Egr1 at transcriptional levels in the uterus.
Collectively, these 7 DEGs could be considered as putative EGR1 direct target genes whose transcription is in part regulated by EGR1 in the uterus. Further studies will be focused on these genes to dissect out physical interaction(s)
of EGR1 with EBS in the promoters of these DEGs in the uterus. Egr1 is an immediate early response gene which orchestrates a second wave of expression as transcription factor in various biological events (Milbrandt, 1987; Thiel and Cibelli, 2002) . Estrogen induces Egr1 via ERK1/2 dependent activation of ELK-1 in MCF-7 breast cancer cells (Chen et al., 2004) . factor-II, platelet-derived growth factor-A, and TGF-β1 were known to be direct targets of EGR1 (Svaren et al., 2000) .
In addition, EGR1 is responsible for overexpression of cyclin D2 in DU145 prostate cancer cells (Virolle et al., 2003) . However, to identify direct target genes that are (Cartharius et al., 2005) . By applying it, we were able to confirm that most of EBS are enriched within -500 bp promoter sequence. This result is consistent with a previous report that most EBS are enriched in -500 bp promoter region of EGR1 target genes in M12 prostate cancer cells (Arora et al., 2008) . Promoters of MMP-9, P21, and GDNF have EGR1 consensus binding motifs within -500 bp (Choi et al., 2008; Shin et al., 2009 ). EGR1
consensus binding motifs were found within -500 bp of the LH-β subunit promoter in many species (Lee et al., 1996) .
Furthermore, another bioinformatic tool, Promo, was applied to perform comparative analyses for sequence conservation between several species whose promoter sequences are available (Messeguer et al., 2002) . Since critical sequences 
